investment.com

BridgeBio Pharma, Inc. — insider transactions

22 transactions on record · BBIO · CIK 1743881

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
22
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
4
Bought, 3m
$0
Sold, 3m
$23.5M
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$10.1M
2026-07-09
Director share, 12m
90.9%
of transactions where role is stated
Current run
22 sells
consecutive same-direction transactions
Net 3m flow
-$23.5M
purchases minus sales
Total on record
22

Transactions

22 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-09-212026-09-174Kumar NeilDirector, Chief Executive OfficerOpen market sale8,721$69.01$601.9Kfiling
2026-09-212026-09-174Kumar NeilDirector, Chief Executive OfficerOpen market sale1,279$69.57$89Kfiling
2026-08-202026-08-182Kumar NeilDirector, Chief Executive OfficerOpen market sale17,279$82.21$1.4Mfiling
2026-08-202026-08-182Kumar NeilDirector, Chief Executive OfficerOpen market sale14,602$82.99$1.2Mfiling
2026-08-202026-08-191Kumar NeilDirector, Chief Executive OfficerOpen market sale8,100$83.86$679.3Kfiling
2026-08-202026-08-182Kumar NeilDirector, Chief Executive OfficerOpen market sale1,900$81.15$154.2Kfiling
2026-08-202026-08-191Kumar NeilDirector, Chief Executive OfficerOpen market sale1,800$84.69$152.4Kfiling
2026-08-202026-08-182Kumar NeilDirector, Chief Executive OfficerOpen market sale1,199$83.77$100.4Kfiling
2026-08-202026-08-191Kumar NeilDirector, Chief Executive OfficerOpen market sale100$85.65$8.6Kfiling
2026-08-182026-08-162Apuli MaricelChief Accounting OfficerShares withheld for tax4,714$79.86$376.5Kfiling
2026-08-032026-07-304Apuli MaricelChief Accounting OfficerOpen market sale2,000$80.06$160.1Kfiling
2026-07-132026-07-094Cook Jennifer E.DirectorExercise of derivative17,167$16.75$287.5Kfiling
2026-07-132026-07-094Cook Jennifer E.DirectorExercise of derivative19,000$8.45$160.6Kfiling
2026-07-132026-07-094Cook Jennifer E.DirectorOpen market sale36,167$84.00$3Mfiling
2026-07-132026-07-094Cook Jennifer E.DirectorExercise of derivative112,422$0.00—filing
2026-07-132026-07-094Cook Jennifer E.DirectorExercise of derivative112,422$29.00$3.3Mfiling
2026-07-132026-07-094Cook Jennifer E.DirectorOpen market sale112,422$90.00$10.1Mfiling
2026-07-132026-07-094Cook Jennifer E.DirectorExercise of derivative17,167$0.00—filing
2026-07-132026-07-094Ellis AndreaDirectorExercise of derivative17,167$0.00—filing
2026-07-132026-07-094Cook Jennifer E.DirectorExercise of derivative19,000$0.00—filing
2026-07-132026-07-094Ellis AndreaDirectorExercise of derivative17,167$16.75$287.5Kfiling
2026-07-132026-07-094Ellis AndreaDirectorOpen market sale17,167$84.00$1.4Mfiling

Source: U.S. Securities and Exchange Commission, EDGAR

BridgeBio Pharma, Inc. insider transactions — 22 filings on record — investment.com